BioRestorative Therapies, Inc. — 8-K Filings
160 8-K filings on record
This page lists all 8-K filings submitted to the SEC by BioRestorative Therapies, Inc. (BRTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. BioRestorative Therapies, Inc. has filed 160 8-K documents with the SEC since 2010. To view all SEC filings by BioRestorative Therapies, Inc., see the full filings list.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001493152-26-006837 | Feb 17, 2026 | Feb 11, 2026 |
| 8-K | THIRD QUARTER 2025 FINANCIAL RESULTS | 0001021771-25-000148 | Nov 12, 2025 | — |
| 8-K | 8-K | 0001493152-25-017446 | Oct 8, 2025 | Oct 6, 2025 |
| 8-K | ANNUAL MEETING VOTE | 0001021771-25-000131 | Sep 25, 2025 | Sep 18, 2025 |
| 8-K | PRESENTATION MATERIALS | 0001021771-25-000116 | Aug 14, 2025 | — |
| 8-K | Q2 2025 EARNINGS, BUSINESS UPDATE AND CONFERENCE CALL | 0001021771-25-000113 | Aug 12, 2025 | — |
| 8-K | PRESENTATION - INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH | 0001021771-25-000092 | Jun 13, 2025 | — |
| 8-K | FIRST QUARTER 2025 AND BUSINESS UPDATE CONFERENCE CALL | 0001021771-25-000079 | May 14, 2025 | — |
| 8-K | CHANGE IN ACCOUNTANTS | 0001021771-25-000074 | Apr 21, 2025 | Apr 16, 2025 |
| 8-K | FINANCIAL RESULTS YEAR ENDED DECEMBER 31, 2024 AND CONFERENCE CALL | 0001021771-25-000066 | Mar 27, 2025 | — |
| 8-K | ORS PRESENTATION | 0001021771-25-000031 | Feb 10, 2025 | — |
| 8-K | THIRD QUARTER RESULTS AND ORS PRESENTATION | 0001021771-24-000195 | Nov 13, 2024 | Nov 12, 2024 |
| 8-K | ADDITIONAL PRELIMINARY PHASE 2 DATA AND REVIEW OF THIRD QUARTER CONFERENCE CALL | 0001021771-24-000190 | Nov 7, 2024 | Nov 6, 2024 |
| 8-K | RODMAN & RENSHAW AT THE MARKET OFFERING AGREEMENT | 0001021771-24-000188 | Nov 6, 2024 | Nov 1, 2024 |
| 8-K | SHAREHOLDER VOTE | 0001021771-24-000180 | Sep 23, 2024 | Sep 19, 2024 |
| 8-K | SECOND QUARTER RESULTS | 0001021771-24-000166 | Aug 13, 2024 | — |
| 8-K | PRESS RELEASE RE SECOND QUARTER RESULTS AND CONFERENCE CALL | 0001021771-24-000158 | Aug 6, 2024 | — |
| 8-K | RE DELISTING | 0001021771-24-000142 | May 24, 2024 | May 22, 2024 |
| 8-K | RE: RESTATEMENT | 0001021771-24-000140 | May 24, 2024 | May 23, 2024 |
| 8-K | RE PRESENTATION MATERIALS | 0001021771-24-000068 | Mar 12, 2024 | Mar 11, 2024 |
| 8-K | FORM 8-K DATED FEBRUARY 6, 2024 | 0001021771-24-000033 | Feb 8, 2024 | Feb 6, 2024 |
| 8-K | RE AUTOLOGOUS STEM CELL THERAPY POSTER | 0001021771-24-000027 | Feb 5, 2024 | — |
| 8-K | PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL | 0001021771-24-000025 | Feb 1, 2024 | — |
| 8-K | SHAREHOLDER VOTE | 0001021771-23-000094 | Sep 15, 2023 | Sep 13, 2023 |
| 8-K | FORM 8-K DATED JULY 11, 2023 | 0001021771-23-000057 | Jul 13, 2023 | Jul 11, 2023 |
| 8-K | — | 0001493152-23-012377 | Apr 14, 2023 | — |
| 8-K | RE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT | 0001021771-23-000037 | Apr 6, 2023 | — |
| 8-K | RE REINCORPORATION | 0001021771-23-000002 | Jan 5, 2023 | Dec 29, 2022 |
| 8-K | ANNUAL SHAREHOLDER MEETING | 0001021771-22-000060 | Nov 9, 2022 | Nov 3, 2022 |
| 8-K | FORM 8-K RE CERTIFICATE OF DESIGNATION SERIES B | 0001021771-22-000051 | Sep 13, 2022 | Sep 8, 2022 |
| 8-K | RE CFO | 0001021771-21-000099 | Dec 8, 2021 | Dec 3, 2021 |
| 8-K | 8-K DATED NOVEMBER 16, 2021 RE AUTHORIZED SHARE REDUCTION | 0001021771-21-000092 | Nov 19, 2021 | Nov 16, 2021 |
| 8-K | FORM 8-K DATED NOVEMBER 9, 2021 RE PUBLIC OFFERING | 0001021771-21-000089 | Nov 15, 2021 | Nov 9, 2021 |
| 8-K | FORM 8-K DATED NOVEMBER 4, 2021 | 0001021771-21-000087 | Nov 8, 2021 | Nov 4, 2021 |
| 8-K | FORM 8-K DATED OCTOBER 26, 2021 RE REVERSE SPLIT | 0001021771-21-000076 | Oct 26, 2021 | — |
| 8-K | FORM 8-K DATED OCTOBER 14, 2021 | 0001021771-21-000074 | Oct 20, 2021 | Oct 14, 2021 |
| 8-K | 8-K DATED AUGUST 17, 2021 RE: SHAREHOLDER VOTE | 0001021771-21-000066 | Aug 17, 2021 | — |
| 8-K | BIORESTORATIVE FORM 8-K DATED MARCH 18, 2021 | 0001021771-21-000020 | Mar 19, 2021 | Mar 18, 2021 |
| 8-K | FORM 8-K DATED JANUARY 5, 2021 RE: LETTER TO SHAREHOLDERS | 0001021771-21-000002 | Jan 6, 2021 | Jan 5, 2021 |
| 8-K | FORM 8-K DATED DECEMBER 1, 2020 RE: CHANGE IN ACCOUNTANTS | 0001021771-20-000083 | Dec 4, 2020 | Dec 1, 2020 |
| 8-K | FORM 8-K DATED NOVEMBER 16, 2020 RE: REORGANIZATION | 0001021771-20-000081 | Nov 20, 2020 | Nov 16, 2020 |
| 8-K | FORM 8-K DATED OCTOBER 30, 2020 RE: ORDER OF BANKRUPTCY COURT | 0001021771-20-000079 | Nov 5, 2020 | Oct 30, 2020 |
| 8-K | FORM 8K DATED APRIL 23, 2020 | 0001021771-20-000044 | Apr 28, 2020 | Apr 23, 2020 |
| 8-K | FORM 8-K DATED MARCH 30, 2020 | 0001021771-20-000041 | Apr 3, 2020 | Mar 30, 2020 |
| 8-K | FORM 8-K DATED MARCH 16, 2020 | 0001021771-20-000036 | Mar 20, 2020 | Mar 16, 2020 |
| 8-K | FORM 8-K DATED FEBRUARY 28, 2020 | 0001021771-20-000031 | Mar 5, 2020 | Feb 28, 2020 |
| 8-K | FORM 8-K DATED FEBRUARY 20, 2020 | 0001021771-20-000029 | Feb 26, 2020 | Feb 20, 2020 |
| 8-K | FEBRUARY 20, 2020 | 0001021771-20-000027 | Feb 20, 2020 | — |
| 8-K | FORM 8-K DATED FEBRUARY 13, 2020 | 0001021771-20-000025 | Feb 14, 2020 | Feb 13, 2020 |
| 8-K | FORM 8-K DATED FEBRUARY 10, 2020 | 0001021771-20-000023 | Feb 11, 2020 | — |